← All organizations
Highest phase reached
Phase 4
First clinical trial
Feb 1, 2005Last known activity
Jul 28, 2021
Acquired by Merck on Apr 17, 2023
Timeline
1990s
- Jun 1, 1995
Prometheus Inc.— Founded
2000s
- Jan 1, 2001
Faro Pharmaceuticals— Acquired
2020s
- Apr 17, 2023
Merck— Acquired By
Drugs by trial phase (24 distinct, 28 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (11 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (31)
- NCT05013905Lead sponsorPhase 2Jul 28, 2021
- NCT04996797Lead sponsorPhase 2Jul 14, 2021
- NCT04676178Study chairPhase 1Dec 14, 2020
- NCT04676178Lead sponsorPhase 1Dec 14, 2020
- NCT03898856CollaboratorPhase 4Apr 1, 2019
- NCT03260504CollaboratorPhase 1Sep 28, 2018
- NCT03476174CollaboratorPhase 2May 7, 2018
- NCT03395028CollaboratorEarly Phase 1Jan 15, 2018
- NCT03215810CollaboratorPhase 1Oct 11, 2017
- NCT02964078CollaboratorPhase 2Apr 11, 2017
- NCT02796352CollaboratorPhase 2Sep 1, 2016
- NCT02849951Lead sponsorPhase 3Jul 1, 2016
- NCT02652455CollaboratorEarly Phase 1Mar 2, 2016
- NCT02500576CollaboratorPhase 2Aug 7, 2015
- NCT02340676CollaboratorPhase 2Feb 1, 2015
Details
- Founded
- San Diego, CA, US Jun 1, 1995
- Last known activity
- Jul 28, 2021